300
Participants
Start Date
October 2, 2022
Primary Completion Date
March 2, 2026
Study Completion Date
March 2, 2026
Zinc Acexamate
"The experimental group will receive ACZ at a daily dose of 600 mg, equivalent to 100mg of elemental zinc (one hard gelatin capsule of 300 mg of ACZ twice a day). Treatment will be stopped when the patient presents any of the events that define the main endpoint of the study.~The control group will receive twice a day orally hard gelatin capsules, identical to those of ACZ, in color, weight and nature, but containing an inert preparation (isomaltose)."
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
Hospital General Universitario Gregorio Marañon
OTHER
Hospital Vall d'Hebron
OTHER
Hospital Universitario Puerta del Hierro
UNKNOWN
Hospital Clinic of Barcelona
OTHER
Hospital Universitario Central de Asturias
OTHER
Complejo Hospitalario de Toledo
OTHER
Germans Trias i Pujol Hospital
OTHER
Hospital Universitario Marqués de Valdecilla
OTHER
Hospital Miguel Servet
OTHER
Parc Taulí Hospital Universitari
OTHER
Hospital de la Santa creu i Sant Pau - Barcelona
OTHER
Hospital Universitari de Bellvitge
OTHER
Hospital del Mar
OTHER
University Hospital of Girona Dr. Josep Trueta
NETWORK
Hospital Universitari Vall d'Hebron Research Institute
OTHER